PMC4886031_01
Acute pulmonary oedema following rituximab treatment.
cnd-0006-0032-g01.jpg
PMC4886031_01_cnd-0006-0032-g01.jpg
F1
Two days after the initial dose of rituximab, she developed acute respiratory distress and was found to be in florid pulmonary oedema (fig. 1).
MRI of the brain showing high T2 and FLAIR signal in the occipital and posterior parietal subcortical white matter consistent with PRES following treatment with rituximab.
cnd-0006-0032-g02.jpg
PMC4886031_01_cnd-0006-0032-g02.jpg
F2
MRI of the head revealed subcortical white matter high T2 and FLAIR signal in the occipital and posterior parietal lobes consistent with PRES (fig. 2).